EMEA-000455-PIP02-10-M09
Key facts
| Invented name |
Brintellix
|
| Active substance |
Vortioxetine
|
| Therapeutic area |
Psychiatry
|
| Decision number |
P/0337/2022
|
| PIP number |
EMEA-000455-PIP02-10-M09
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of major depressive disorder
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
H. Lumdbeck A/S
E-mail: commres2738@lundbeck.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|